A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Cancer Recurrence, High Risk Prostate Cancer, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT02960022
Phase: PHASE2
Trial Summary: The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:

Pin It on Pinterest